Commercial Surveys

Commercial Surveys

The Scenario of Iran's Vaccine Market Future in 2035

Document Type : Original Article

Authors
1 Department of Business Management, Yazd Branch, Islamic Azad University, Yazd, Iran
2 Professor, Department of Business Management, Yazd Branch, Islamic Azad University, Yazd, Iran
3 Assistant Professor, Department of Business Management, Yazd Branch, Islamic Azad University, Yazd, Iran
4 Professor, Department of Management and Information, Iran University of Medical Sciences and Health Services, Tehran, Iran
Abstract
Incentive marketing is a type of marketing and vaccine is one of the products that especially adults and the elderly need this type of marketing. If the marketing managers of companies have the ability to predict the possible future, they will be stronger in their planning. One of the most useful tools for predicting the future is the scenario. The aim of the current research is to develop suitable scenarios for vaccine marketing considering the aging population of Iran. The research is based on a constructivist paradigm, which was conducted with a practical orientation and in the form of a descriptive research and in a cross-sectional manner based on a survey approach (interview and questionnaire) and using library and field studies in 5 steps. Data analysis was done with the help of SPSS and Scenario Wizard software. Findings, the vaccine portfolio of 1414 considers the current vaccines and 6 other vaccines. Also, 29 variables affecting vaccine marketing were identified in the form of 7 factors affecting vaccine marketing. These 7 factors ultimately created two compatible scenarios. The research, due to its novelty and practicality, has contributed to the development of existing knowledge in the field of the vaccine market and health economics and shows a way to create demand and motivation for vaccine consumption among the elderly and adults, in the further growth and prosperity of this The industry should help and be successful in increasing the quality of life and lower treatment costs for the society and the government.
Keywords

Subjects


  1. Ciabattini et al. (2018). Vaccination in the elderly: The challenge of immune changes with aging. Seminars in Immunology, 83-94. https://doi.org/10.1016/j.smim.2018.10.010
  2. Mahalleh A. (2016, 06 30). Pharmaceutical industry review and analysis. Retrieved from Pasargad Bank Brokerage: pasargad.irbrokersite.ir (in Persian)

Ayatollahi J. (2007). Vaccines aren’t just for kids. Teacher Growth, 28-29. (in Persian)

Ayeneh M., Mahmodian Y. (2022). Investigating and Ranking Factors Affecting the Penetration Rate in the Drug Market (Case Study: Approved Drugs for the Treatment of Covid-19 Disease). Journal of Trade Studies, 105- 126. 10.22034/ijts.2022.251857 (in Persian)

Bekr S., Mehrani H., Gh. Hoseini M., Tootian S. (2020). Dynamic Analysis of Marketing Mix Elements Using a Futures Approach. Management Futures Quarterly, 41-60. 10.30495/jmfr.2022.20263 (in Persian)

Bonanni P. et al. (2018). Focusing on the implementation of 21st century vaccines for adults. Vaccine,5358-5365. https://doi.org/10.1016/j.vaccine.2017.07.100

Cai J., Stoyanov A. (2016). Population aging and comparative advantage. Journal of International Economics, 1-21. https://doi.org/10.1016/j.jinteco.2016.04.006

Cylus J., etal. (2022). Population ageing and health financing: A method for forecasting two sides of the same coin. Health Policy, 1226-1232. https://doi.org/10.1016/j.healthpol.2022.10.004

  1. Graf D., Whestphal L., E. Hallgreen C. (2024). The life cycle of vaccines evaluated by the European Medicines Agency. Vaccine, 126186. https://doi.org/10.1016/j.vaccine.2024.126186

Debora D. G., Lukas W. & Christine E. H. (2024). The life cycle of vaccines evaluated by the European Medicines Agency. Copenhangen: Copenhagen Centre for Regulatory Science. https://doi.org/10.1016/j.vaccine.2024.126186

Doherty M. et al. (2016). Vaccine impact: Benefits for human health. Vaccine, 6707-6714. https://doi.org/10.1016/j.vaccine.2016.10.025

Drumond P. et all. (2022). Strategy study to prioritize marketing criteria: an approach in the light of the DEMATEL method. Procedia Computer Science, 448-452. https://doi.org/10.1016/j.procs.2022.01.054

Ellison D., White D., C. Farrar F. (2015). Aging Population. Nursing Clinics of North America, 185-213. https://doi.org/10.1016/j.cnur.2014.10.014

Ezzatpanah Y. (2024). The role and position of advertising principles with customers in marketing and business management. Quarterly Journal of Management Research in the Islamic World. (in Persian)

Fang T., Huang y.& Avgerinos E. (2018). When marketing and manufacturing departments integrate: The influences of market newness and competitive intensity. Amsterdam: Industrial Marketing Management. https://doi.org/10.1016/j.indmarman.2018.06.007

Fathi E. (2020). The phenomenon of population aging in Iran. IJOSS, 387-413. 20.1001.1.25385798.1398.30.2.7.6 (in Persian)

Gh. Zaveshti M., Gh. Koochaki A. (2015). The use of scenario writing in political and security crises. Crisis Management Studies, 697. (in Persian)

Heo Y. J. (2022). Population aging and house prices: Who are we calling old? The Journal of the Economics of Ageing, 20-25. https://doi.org/10.1016/j.jeoa.2022.100417

Hesami Sh., Veisi K., Aliabadi S. (2024). Psychometrics and Testing of a Motivational Marketing Model based on Psychological Components in Sports. Sports Psychology, 186-200. 10.48308/mbsp.2022.104465.1115 (in Persian)

Imam Khomeini International University (2019). Specialized meeting on scenario writing in futures studies [Recorded by Pedraam A.]. Ghazvin, Ghazvin, Iran. (in Persian)

Independant Persian. (2022). London: Independant Persian. (in Persian)

  1. Nowak G. et al. (2015). Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices. Vaccine, 4204-4211. https://doi.org/10.1016/j.vaccine.2015.04.039

Karafillakis E., Larson H.J. (2017). The benefit of the doubt or doubts over benefits? A systematic literature review of percieved risks of vaccines in European populations. Amsterdam: Vaccine. https://doi.org/10.1016/j.vaccine.2017.07.061

Lopreite M.& Mauro M. (2017). The effects of population ageing on healthcare expenditure. Amsterdam: Health Policy. https://doi.org/10.1016/j.healthpol.2017.03.015

Sarmai Z., Bazargan A., Hejazi E. (2023). Research methods in behavioral sciences. Tehran: Aagah. (in Persian)

  1. Bennet E., et al. (2017). I’ll do anything to maintain my health. Amsterdam: Body Image, 71-80. https://doi.org/10.1016/j.bodyim.2017.03.002
  2. Orge M. P., R. Vidal P. P., Barrios J. M., Fernandez J. U. (2018). Vaccinating is not just a matter for children: Adult immunization schedule. Vacunas, 4-7. https://doi.org/10.1016/j.vacune.2018.03.004

Volken T. et al. (2017). Temporal change to self rated health in Swiss population from 1997 to 2012. Public Health, 152-165.  https://doi.org/10.1016/j.puhe.2017.07.007

Volken T. et al. (2017). Temporal change to self rated health in Swiss population from 1997 to 2012. Public Health, 152-165.  https://doi.org/10.1016/j.puhe.2017.07.007

Vrhovec J., Tajnikar M. (2016). Population ageing and healthcare demand: The case of Slovenia. Health Policy, 1329-1336. https://doi.org/10.1016/j.healthpol.2016.09.007

  1. Keeler L., J. Bernstein M. (2021). The future of aging in smart environments: Four scenarios of the United States in 2050. Futures, 102830. https://doi.org/10.1016/j.futures.2021.102830

W.H.O. (2024, 10 1). Ageing and health. Retrieved from W.H.O: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health

Wang Q., Wang X. & Li R. (2022). Does population aging reduce environmental pressures from urbanization in 156 countries? Science of The Total Environment, 56-62. https://doi.org/10.1016/j.scitotenv.2022.157330

Wikipedia. (2024, 8 2). Marketing Management. Retrieved from Wikipedia: https://fa.wikipedia.org/wiki. (in Persian)

World Health Organization. (2023, December 1). Global vaccine market report. Retrieved from World Health Organization:https://cdn.who.int/media/docs/default-source/immunization/mi4a/who_gat_008_global_vaccine_market_report_march_12.pdf?sfvrsn=a61f4733_1

 

Volume 22, Issue 129 - Serial Number 129
January and February 2025
Pages 115-132

  • Receive Date 04 August 2024
  • Revise Date 04 November 2024
  • Accept Date 06 November 2024